Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid.

Westergaard M, Henningsen J, Svendsen ML, Johansen C, Jensen UB, Schrøder HD, Kratchmarova I, Berge RK, Iversen L, Bolund L, Kragballe K, Kristiansen K.

J Invest Dermatol. 2001 May;116(5):702-12.

2.

RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations.

Li M, Chiba H, Warot X, Messaddeq N, Gérard C, Chambon P, Metzger D.

Development. 2001 Mar;128(5):675-88.

3.

Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4.

Echtermeyer F, Streit M, Wilcox-Adelman S, Saoncella S, Denhez F, Detmar M, Goetinck P.

J Clin Invest. 2001 Jan;107(2):R9-R14.

4.

Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice.

Gallucci RM, Simeonova PP, Matheson JM, Kommineni C, Guriel JL, Sugawara T, Luster MI.

FASEB J. 2000 Dec;14(15):2525-31.

PMID:
11099471
5.

Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis.

Li M, Indra AK, Warot X, Brocard J, Messaddeq N, Kato S, Metzger D, Chambon P.

Nature. 2000 Oct 5;407(6804):633-6.

PMID:
11034212
6.

Delayed wound healing in immunodeficient TGF-beta 1 knockout mice.

Crowe MJ, Doetschman T, Greenhalgh DG.

J Invest Dermatol. 2000 Jul;115(1):3-11.

7.

Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice.

Streit M, Velasco P, Riccardi L, Spencer L, Brown LF, Janes L, Lange-Asschenfeldt B, Yano K, Hawighorst T, Iruela-Arispe L, Detmar M.

EMBO J. 2000 Jul 3;19(13):3272-82.

8.

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta).

Peters JM, Lee SS, Li W, Ward JM, Gavrilova O, Everett C, Reitman ML, Hudson LD, Gonzalez FJ.

Mol Cell Biol. 2000 Jul;20(14):5119-28.

9.

Farnesol stimulates differentiation in epidermal keratinocytes via PPARalpha.

Hanley K, Kömüves LG, Ng DC, Schoonjans K, He SS, Lau P, Bikle DD, Williams ML, Elias PM, Auwerx J, Feingold KR.

J Biol Chem. 2000 Apr 14;275(15):11484-91.

10.

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs.

He TC, Chan TA, Vogelstein B, Kinzler KW.

Cell. 1999 Oct 29;99(3):335-45.

11.

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance.

Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Kadowaki T, et al.

Mol Cell. 1999 Oct;4(4):597-609.

12.

PPAR gamma is required for placental, cardiac, and adipose tissue development.

Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM.

Mol Cell. 1999 Oct;4(4):585-95.

13.

Peroxisome proliferator-activated receptors: nuclear control of metabolism.

Desvergne B, Wahli W.

Endocr Rev. 1999 Oct;20(5):649-88. Review. No abstract available.

PMID:
10529898
14.

Long-term culture of murine epidermal keratinocytes.

Hager B, Bickenbach JR, Fleckman P.

J Invest Dermatol. 1999 Jun;112(6):971-6.

15.

A unified nomenclature system for the nuclear receptor superfamily.

Nuclear Receptors Nomenclature Committee.

Cell. 1999 Apr 16;97(2):161-3. No abstract available.

16.

Correlation between expression of peroxisome proliferator-activated receptor beta and squamous differentiation in epidermal and tracheobronchial epithelial cells.

Matsuura H, Adachi H, Smart RC, Xu X, Arata J, Jetten AM.

Mol Cell Endocrinol. 1999 Jan 25;147(1-2):85-92.

PMID:
10195695
17.

Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes.

Rivier M, Safonova I, Lebrun P, Griffiths CE, Ailhaud G, Michel S.

J Invest Dermatol. 1998 Dec;111(6):1116-21.

18.

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC, Najib J, Maclouf J, Tedgui A.

Nature. 1998 Jun 25;393(6687):790-3.

PMID:
9655393
19.
20.

Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARalpha.

Hanley K, Jiang Y, He SS, Friedman M, Elias PM, Bikle DD, Williams ML, Feingold KR.

J Invest Dermatol. 1998 Apr;110(4):368-75.

Supplemental Content

Support Center